Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes

被引:27
作者
Anderson, James B. [1 ]
Martin, Stephen A. [2 ,3 ]
Gadomski, Anne [4 ]
Krupa, Nicole [4 ]
Mullin, Daniel [2 ,3 ]
Cahill, Amber [2 ]
Jenkins, Paul [4 ]
机构
[1] Bassett Med Ctr, Dept Med, One Atwell Rd, Cooperstown, NY 13326 USA
[2] Univ Massachusetts, Sch Med, Family Med & Community Hlth, Worcester, MA USA
[3] UMassMem Healthcare, Worcester, MA USA
[4] Bassett Res Inst, Bassett Med Ctr, Cooperstown, NY USA
关键词
Opioid use disorder; medication assisted treatment; treatment retention rate; medications for opioid use disorder; primary care; buprenorphine; Project ECHO; MEDICATION-ASSISTED TREATMENT; RETENTION; CAPACITY; COVID-19; IMPACT; STATES;
D O I
10.1080/08897077.2021.1931633
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Our rural health system sought to (1) increase the number of primary care clinicians waivered to prescribe buprenorphine for treatment of opioid use disorder (OUD) and (2) consequently increase the number of our patients receiving this treatment. Methods: We used the Project for Extension for Community Health Outcomes (ECHO) tele-education model as an implementation strategy. We examined the number of clinicians newly waivered, the number of patients treated with buprenorphine, the relationship between clinician engagement with ECHO training and rates of buprenorphine prescribing, and treatment retention at 180 days. Results: The number of clinicians with a waiver and number of patients treated increased during and after ECHO training. There was a moderate correlation between the number of ECHO sessions attended by a clinician and number of their buprenorphine prescriptions (r = 0.50, p = 0.01). The 180-day retention rate was 80.7%. Conclusions: Project ECHO was highly effective for increasing access to this evidence-based treatment. The high retention rate in this rural context indicates that most patients are increasing their likelihood of favorable outcomes.
引用
收藏
页码:222 / 230
页数:9
相关论文
共 56 条
[11]   COVID-19 as a Frying Pan: The Promise and Perils of Pandemic-driven Reform [J].
del Pozo, Brandon ;
Beletsky, Leo ;
Rich, Josiah D. .
JOURNAL OF ADDICTION MEDICINE, 2020, 14 (05) :E144-E146
[12]  
Ducharme S, 2012, CAN FAM PHYSICIAN, V58, P37
[13]   Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study [J].
Dupouy, Julie ;
Palmaro, Aurore ;
Fatseas, Melina ;
Auriacombe, Marc ;
Micallef, Joelle ;
Oustric, Stephane ;
Lapeyre-Mestre, Maryse .
ANNALS OF FAMILY MEDICINE, 2017, 15 (04) :355-358
[14]   NEW MODELS OF CARE Hierarchy disruptors: bringing specialist knowledge from hospital to community care [J].
Eaton, Lynn .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
[15]   Long-term treatment with buprenorphine/naloxone in primary care: Results at 2-5 years [J].
Fiellin, David A. ;
Moore, Brent A. ;
Sullivan, Lynn E. ;
Becker, William C. ;
Pantalon, Michael V. ;
Chawarski, Marek C. ;
Barry, Declan T. ;
O'Connor, Patrick G. ;
Schottenfeld, Richard S. .
AMERICAN JOURNAL ON ADDICTIONS, 2008, 17 (02) :116-120
[16]   Availability of Buprenorphine Treatment in the 10 States With the Highest Drug Overdose Death Rates in the United States [J].
Flavin, Lila ;
Malowney, Monica ;
Patel, Nikhil A. ;
Alpert, Michael D. ;
Cheng, Elisa ;
Noy, Gaddy ;
Samuelson, Sarah ;
Sreshta, Nina ;
Boyd, J. Wesley .
JOURNAL OF PSYCHIATRIC PRACTICE, 2020, 26 (01) :17-22
[17]   Nurse Practitioner Prescriptive Authority for Buprenorphine From DATA 2000 to CARA 2016 [J].
Fornili, Katherine S. ;
Fogger, Susanne A. .
JOURNAL OF ADDICTIONS NURSING, 2017, 28 (01) :43-48
[18]   Estimating the impact of drug use on US mortality, 1999-2016 [J].
Glei, Dana A. ;
Preston, Samuel H. .
PLOS ONE, 2020, 15 (01)
[19]   Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder [J].
Haffajee, Rebecca L. ;
Lin, Lewei Allison ;
Bohnert, Amy S. B. ;
Goldstick, Jason E. .
JAMA NETWORK OPEN, 2019, 2 (06) :e196373
[20]  
Health Alert Network, 2020, CDC, V17, P2020